The present invention relates to large scale manufacture of nanoscale microsheets for use in applications such as wound healing or modification of a biological or medical surface.

A system for managing female incontinence includes a body of biocompatible material configured to fit between the labia minora and the vestibule floor, the body having a surface configured to occlude the urethral meatus, an adhesive carried on at least a first portion of the surface and configured to provide a sealing engagement between the body and the urethral meatus, and a substance carried by at least one of the body and the adhesive and configured for controlling the odor of the general vaginal-urethral area of a female.

A curable composition for use in wound care comprising, apportioned between at least one Part A and at least one Part B: one or more alkenyl-group containing polymers (i) having at least one alkenyl group or moiety per molecule, one or more SiH-containing polymers (ii) having at least one Si—H unit per molecule; and a catalyst (iii) for curing by addition of alkenyl-containing polymer (i) to SiH-containing polymer (ii), Part A and Part B independently having viscosity at 23° C. in the range 5-300 Pa.Math.s, preferably 10-100 Pa.Math.s, at a shearing rate of 10 s.sup.−1, and when combined in one Part having cure time at 23° C. in the range from 0.5 min to 25 min, wherein when dispensed into a location about a wound dressing, said wound dressing overlying a wound site and skin thereabout, said dispensing being so as to intimately contact and overlie an edge of said dressing and skin about said edge, the composition cures in contact with said edge and skin at 32° C. to an elastomer exhibiting zero or low tack at a time in the range from 0.5 to less than 30 minutes, apparatus for use with said composition comprising dispensing apparatus or wound dressing, a kit comprising the same, and methods of dispensing and curing the same and of using the same in sealing a wound dressing and in treating a wound site of a human in need thereof.

A protective device configured in accordance with a particular embodiment includes a cover including a first region that extends over a vulnerable site on a patient and a second region that extends over an area on the patient peripheral to the vulnerable site. The first region of the cover is at least generally impermeable to liquid water. The device further includes an adhesive film and a liquid-absorbing element. The adhesive film is configured to form an adhesive bond between the second region of the cover and the patient. The bond has an inner edge portion positioned toward the vulnerable site and an outer edge portion positioned away from the vulnerable site. The liquid-absorbing element is configured to absorb liquid contamination at the outer edge portion of the bond and/or liquid contamination approaching the outer edge portion of the bond when the cover is operably positioned on the patient.

A bandage system lances a skin tag from a person's body and thereafter projects the wound created. The system has a base layer that is adhesively attached to the person such that the skin tag passes through an opening of the base layer. A cutter is located atop the base layer and uses a pair of blades that are squeezed together to cut the skin tag protruding through the opening. After cutting, a protective layer is adhered to the base layer such that a medicine laden absorbent pad on the protective layer overlays the opening on the base layer absorbing any blood from the wound and applying the medicine to the wound. Thereafter, the system is worn as a typical bandage.

A bandage can be made oversized in width and length with a thick absorbent pad to provide pressure to the wound. The bandage provides a one-step procedure for wounds that need pressure and protection. The individually wrapped bandage is taken from a sterile wrapper to the wound so there is no worry of infection. Pull tabs make the bandage application a sterile procedure. Another bandage has a hard or semi hard cover with optional vent holes incorporated for air circulation. The bandage protects a wound or stitches or any delicate skin problem from being bumped or damaged from ordinary daily labors. The cover can have no pad in it or it can have a pad that can have nothing in it or can have anti-bacterial ointment, or the like, to help fight infection.

A bandage to control bleeding from an open wound has a hemostatic gauze. An absorbent pad is removably attached to the hemostatic gauze.

A natural peptide comprising a cellular growth promoting fragment of a protein selected from SEQ ID NOs: 1 to 13, and a composition comprising a plurality of growth promoting peptides, is described. Also disclosed is the use of the peptides and compositions in prevention of ageing of human skin, treatment of diseases or conditions characterised by damaged epithelial cells or tissue such as colon cancer and peripheral inflammatory disorders, and wound treatment. Specific pea and rice protein derived peptides are described in SEQ ID NOs: 15 to 505, and 546 to 704.

In some embodiments, a wound monitoring and/or therapy apparatus includes a wound dressing configured to be positioned in contact with a wound, the wound dressing comprising one or more sensors configured to obtain measurement data of at least one of the wound or periwound. The apparatus can also include a controller configured to maintain a device clock indicative of a non-real time clock, receive measurement data obtained by the one or more sensors, and transmit measurement data to a remote computing device according to a security protocol, the security protocol comprising including the device clock associated with the measurement data in the transmission.

The present disclosure relates to apparatus for covering a burn or other wound in ways that prevent or limit touching the wound. The present disclosure describes Burn Bandages that may include domes or structures that bridge over a wide range of a burn or wound size. In certain instances these structures may expand in one or more directions as they are adjusted to fit to a particular burn or wound size. Such bridging structures may include airways, openings, or voids that promote air/oxygen flow to the wound as the Burn Bandage sits upon surfaces or pads that contact healthy surrounding tissue while they cover a wound site. The apparatus may be any shape including, yet not limited to, a circle, a rectangle, a square, a hexagon, an octagon, an oval, a cone, a cylinder, have a semi-cylindrical shape, or that have any another geometric shape.